World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
48
Citations
7226
World Ranking
5998
National Ranking
3249

Overview

Armin Szegedi is affiliated with MSD (United States) and is active in research primarily within the field of Medicine. Their work spans several subfields including Psychiatry and Mental Health, Pathology and Forensic Medicine, Sensory Systems, and Surgery. The main research focus is on migraine and headache studies, with considerable contributions to trigeminal neuralgia and treatments as well as psychosomatic disorders and related therapeutic approaches.

Their scholarly output includes research on olfactory and sensory function studies, cardiovascular syncope and autonomic disorders, and historical and scientific studies. Szegedi's research has been published frequently in the following venues:

  • Neurology
  • The Lancet Neurology
  • Headache The Journal of Head and Face Pain
  • Cephalalgia

Significant recent papers by Szegedi include:

  • Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial, 2020, The Lancet Neurology
  • Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis, 2021, Headache The Journal of Head and Face Pain
  • Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications, 2020, Cephalalgia
  • Efficacy Is Maintained With Long-term Intermittent Use of Ubrogepant for the Acute Treatment of Migraine (111), 2020, Neurology
  • Ubrogepant Achieves Onset of Pain Relief at 1 Hour for the Acute Treatment of Migraine (1223), 2020, Neurology

The researcher has collaborated frequently with several coauthors including Joel M. Trugman, Peter J. Goadsby, David W. Dodick, Kaifeng Lu, and Michelle Finnegan. These partnerships have contributed to multiple publications and research projects, particularly in the study and treatment of migraine and headache.

The number of publications and citations suggests ongoing engagement with clinical and therapeutic aspects of migraine treatment. Although there are no listed book publications or awards, the focus on relevant clinical trials and analyses defines Szegedi's contributions to the field.

Best Publications

  • Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.

    Armin Szegedi;Wim T. Jansen;Arjen P. P. van Willigenburg;Egbert van der Meulen

  • Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).

    Matthias J. Müller;Hubertus Himmerich;Barbara Kienzle;Armin Szegedi

  • Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.

    A Szegedi;R Kohnen;A Dienel;M Kieser

  • Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis.

    Christoph Fehr;Thomas Sander;Andre Tadic;Kirsten P. Lenzen

  • Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

    Armin Szegedi;Matthias J Müller;Ion Anghelescu;Christoph Klawe

  • What does the HAMD mean

    Stefan Leucht;Hein Fennema;Rolf Engel;Marion Kaspers-Janssen

  • The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.

    A Szegedi;D Rujescu;A Tadic;M J Müller

  • Mirtazapine Compared With Paroxetine in Major Depression

    Otto Benkert;Armin Szegedi;Ralf Kohnen

  • Pharmacokinetic Interactions of Clozapine With Selective Serotonin Reuptake Inhibitors: Differential Effects of Fluvoxamine and Paroxetine in a Prospective Study

    Hermann Wetzel;Ion Anghelescu;Armin Szegedi;Jasmin Wiesner

  • Is There a Common Resilience Mechanism Underlying Antidepressant Drug Response? Evidence From 2848 Patients

    Hans H. Stassen;Jules Angst;Daniel Hell;Christian Scharfetter

  • Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.

    A. Tadic;D. Rujescu;A. Szegedi;I. Giegling

  • Moderate and severe depression: Gradations for the Montgomery–Åsberg Depression Rating Scale

    Matthias J Müller;Armin Szegedi;Hermann Wetzel;Otto Benkert

  • Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior.

    Gunter Schumann;Monika Johann;Josef Frank;Ulrich Preuss

  • Superior efficacy of St John's wort extract WS®5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

    Siegfried Kasper;Ion-George Anghelescu;Armin Szegedi;Angelika Dienel

  • Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.

    A Szegedi;H Wetzel;M Leal;S Härtter

  • Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).

    A Scheurich;M J Müller;H Wetzel;I Anghelescu

  • Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.

    Florian Muller-Siecheneder;Matthias J. Muller;Andreas Hillert;Armin Szegedi

  • The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy

    Christoph Fehr;Nina Grintschuk;Armin Szegedi;Ion Anghelescu

  • A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment

    John M. Kane;Mary Mackle;Linda Snow-Adami;Jun Zhao

  • Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.

    Armin Szegedi;Joseph R. Calabrese;Let Stet;Mary Mackle

  • An overview of the clinical efficacy of mirtazapine.

    O. Benkert;M. Muller;A. Szegedi

Frequent Co-Authors

Thomas Sander
Thomas Sander University of Cologne
Jules Angst
Jules Angst University of Zurich
Gunter Schumann
Gunter Schumann King's College London
Rolf R. Engel
Rolf R. Engel Ludwig-Maximilians-Universität München
Michael E. Thase
Michael E. Thase University of Pennsylvania
H.-J. Möller
H.-J. Möller Ludwig-Maximilians-Universität München
Stefan Wiemann
Stefan Wiemann German Cancer Research Center
Martin Hautzinger
Martin Hautzinger University of Tübingen
Sven Cichon
Sven Cichon University of Basel
Mark Lathrop
Mark Lathrop McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Psychology degree in the USA opens a range of online program options and career directions, especially in the counseling profession. Many accredited universities offer flexible online degrees that lead to careers in counseling, mental health, and related fields.

If your goal is to start working as a counselor quickly, there are several streamlined educational pathways. For example, the quickest path to becoming a counselor in Connecticut emphasizes targeted graduate programs and state-specific licensure requirements. Similarly, if you want information on the shortest path to becoming a counselor in Delaware, you'll find routes focused on fulfilling supervision hours and coursework efficiently.

For students in the Southeast, understanding the quickest path to becoming a counselor in Florida could accelerate your transition into the profession through online and hybrid formats. Those interested in regional differences and innovative approaches should explore Georgia accelerated counseling programs.

No matter which state you choose, online study, careful course selection, and awareness of state licensure processes will help maximize your career opportunities in psychology-related fields.

Best Scientists Citing Armin Szegedi

Trending Scientists

Recently Published Articles